Novel systemic treatments in atopic dermatitis: Are there sex differences?

Atopic dermatitis (AD) is a common inflammatory skin disease with a significant global disease burden. Several mechanisms underlie AD, such as epidermal barrier dysfunction and immune dysregulation, which have led to innovative systemic treatment options. Other inflammatory disorders, as well as inn...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuttle, Katherine L., Forman, Jessica, Beck, Lisa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721130/
https://www.ncbi.nlm.nih.gov/pubmed/35024415
http://dx.doi.org/10.1016/j.ijwd.2021.10.002
_version_ 1784625270457630720
author Tuttle, Katherine L.
Forman, Jessica
Beck, Lisa A.
author_facet Tuttle, Katherine L.
Forman, Jessica
Beck, Lisa A.
author_sort Tuttle, Katherine L.
collection PubMed
description Atopic dermatitis (AD) is a common inflammatory skin disease with a significant global disease burden. Several mechanisms underlie AD, such as epidermal barrier dysfunction and immune dysregulation, which have led to innovative systemic treatment options. Other inflammatory disorders, as well as innate and adaptive immune responses, have noted sex differences, but our article highlights a paucity of data on the impact of sex, gender, and gender identity on the pathophysiology and systemic treatments of AD.
format Online
Article
Text
id pubmed-8721130
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87211302022-01-11 Novel systemic treatments in atopic dermatitis: Are there sex differences? Tuttle, Katherine L. Forman, Jessica Beck, Lisa A. Int J Womens Dermatol Article Atopic dermatitis (AD) is a common inflammatory skin disease with a significant global disease burden. Several mechanisms underlie AD, such as epidermal barrier dysfunction and immune dysregulation, which have led to innovative systemic treatment options. Other inflammatory disorders, as well as innate and adaptive immune responses, have noted sex differences, but our article highlights a paucity of data on the impact of sex, gender, and gender identity on the pathophysiology and systemic treatments of AD. Elsevier 2021-10-12 /pmc/articles/PMC8721130/ /pubmed/35024415 http://dx.doi.org/10.1016/j.ijwd.2021.10.002 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Tuttle, Katherine L.
Forman, Jessica
Beck, Lisa A.
Novel systemic treatments in atopic dermatitis: Are there sex differences?
title Novel systemic treatments in atopic dermatitis: Are there sex differences?
title_full Novel systemic treatments in atopic dermatitis: Are there sex differences?
title_fullStr Novel systemic treatments in atopic dermatitis: Are there sex differences?
title_full_unstemmed Novel systemic treatments in atopic dermatitis: Are there sex differences?
title_short Novel systemic treatments in atopic dermatitis: Are there sex differences?
title_sort novel systemic treatments in atopic dermatitis: are there sex differences?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721130/
https://www.ncbi.nlm.nih.gov/pubmed/35024415
http://dx.doi.org/10.1016/j.ijwd.2021.10.002
work_keys_str_mv AT tuttlekatherinel novelsystemictreatmentsinatopicdermatitisaretheresexdifferences
AT formanjessica novelsystemictreatmentsinatopicdermatitisaretheresexdifferences
AT becklisaa novelsystemictreatmentsinatopicdermatitisaretheresexdifferences

Ejemplares similares